Searchable abstracts of presentations at key conferences on calcified tissues

ba0001oc5.6 | Treatment of osteoporosis | ECTS2013

Testosterone replacement has a substantial benefit on bone mass, fracture incidence, libido, and sexual activities in male cardiac transplant patients: a 5-year randomized prospective controlled trial

Wagner Doris , Prenner Guenther , Dobnig Harald , Dimai Hans Peter , Pieber Thomas , Pilz Stefan , Tomaschitz Andreas , Amrein Karin , Fahrleitner-Pammer Astrid

Hypogonadism is common in cardiac transplant (CTX) patients and exerts negative effects on bone but also on libido and quality of life.We investigated whether testosterone replacement therapy (TRT) has any positive effects on bone mass, fracture incidence, and quality of sex life when administered in addition to ibandronate (IBN) in hypogonadal CTX recipients. 52 male patients entered the study and received IBN (quarterly 2 μg i.v.). 60% of the pati...

ba0001pp99 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

Interrelationship between osteocalcin (bgp) and energetic metabolism in two strains of rats

Marotte Clarisa , Bryk Gabriel , Coronel Magali Zeni , Abrego Paulina , Lucero Diego Martin , Schreier Laura , Portela Maria Luz , Zeni Susana Noemi

It has suggested that BGP is inversely related to body fat. BGP appears to regulate energetic metabolism through the insulin receptor signaling pathway in the osteoblast, which affects bone resorption and BGP activity. Fat tissue is an endocrine organ that secretes different hormones and growth factors; several of them affect bone remodeling and insulin secretion. The present report comparatively studied total BGP levels, glucose homeostasis and body fat mass in spontaneous ob...

ba0001pp307 | Muscle, physical activity and bone | ECTS2013

Muscle power and force may influence cortical bone strength via distinct mechanisms: findings from a cross sectional study of high bone mass cases and controls

Hardcastle Sarah A , Gregson Celia L , Rittweger Jorn , Ward Kate A , Tobias Jon H

Background: Relationships between muscle function and bone have been examined using a range of techniques, with conflicting results. We aimed to determine these associations within an adult population comprising individuals with high bone mass and family controls.Methods: Recruitment was from four UK sites within the high bone mass (HBM) study; cases and unaffected family controls were pooled. Peak ground reaction force and peak power, during a multiple ...

ba0002op6 | (1) | ICCBH2013

Children with nephrotic syndrome have increased tibial bone area but similar volumetric bone mineral density to healthy controls

Moon Rebecca , Gilbert Rodney , Page Anna , Murphy Liam , Taylor Pat , Cooper Cyrus , Dennison Elaine , Davies Justin

Objectives: An increased fracture risk is reported in children requiring recurrent courses of glucocorticoids. Reduced bone mineral density (BMD), particularly in the trabecular compartment, has also been demonstrated in a number of childhood diseases treated with glucocorticoids. The differential contribution of glucocorticoids and underlying inflammatory disease to bone demineralisation is poorly understood. Childhood nephrotic syndrome (NS) often follows a relapsing-remitti...

ba0003oc3.3 | Osteoclasts, gastric hormones and HIF | ECTS2014

Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts

Logan John G , Bassett JH Duncan , Williams Graham R

Thyrotoxicosis results in osteoporosis, and thyroid hormone (T3) stimulates osteoclastic bone resorption by unknown mechanisms. We previously demonstrated that knockout mice lacking thyroid hormone receptor α (TRα0/0) are euthyroid but have high bone mass, whereas mice lacking TRβ (TRβ−/−) are thyrotoxic and osteoporotic. Tartrate resistant acid phosphatase (TRAcP) staining revealed osteoclast numbers were reduced by 13% (<...

ba0003pp213 | Osteoporosis: evaluation and imaging | ECTS2014

HIV patients have deteriorated bone material properties assessed by in vivo microindentation

Guerri-Fernandez Robert , Villar-Garcia Judit , Molina-Morant Daniel , Torres-del-Pliego Elisa , Garcia-Giralt Natalia , Vilaplana-Marz Laia , Rodriguez Maria , Mena Alicia Gonzalez , Knobel Hernando , Nogues Xavier , Mellibovsky Lenoardo , Horcajada Juan Pablo , Diez-Perez Adolfo

There is a growing evidence of the association between HIV infection and fracture risk. Independently of its cause (antiretroviral therapy (ART) or HIV), what remains most important is a prompt diagnosis. Although densitometry is the gold standard, sometimes this technique is not as accurate as necessary in clinical practice. A new validated tool for early and more accurate diagnosis is presented.MethodsIn a HIV group of patients, ...

ba0003pp300 | Osteoporosis: treatment | ECTS2014

Resveratrol supplementation increases vBMD at the spine in obese men: a randomized controlled trial

Ornstrup Marie Juul , Harslof Torben , Kjaer Thomas Nordstrom , Paulsen Soren Kildeberg , Langdahl Bente Lomholt , Pedersen Steen Bonlokke

Background: Resveratrol (RSV) is a natural polyphenolic compound, found in fx grapes, which possesses anti-inflammatory properties. RSV inhibits osteoclast activity and promotes osteoblastogenesis in vitro. Furthermore, RSV protects against bone loss after ovarectomy and immobilization in animal models. RSV treatment of obese men for 4 weeks resulted in an increase in bone specific alkaline phosphatase (BAP).Hypothesis: Low-grade inflammation is...

ba0004p33 | (1) | ICCBH2015

In utero effects of iron status on infant fibroblast growth factor-23 and mineral metabolism

Braithwaite Vickie S , Prentice Ann , Darboe Momodou K , Prentice Andrew M , Moore Sophie E

Fibroblast growth factor-23 (FGF23) is a bone derived phosphate-regulating hormone which is elevated in hypophosphataemic rickets. Recent findings demonstrate iron deficiency as a potential mediator of FGF23 expression and murine studies have shown in utero effects of maternal iron deficiency leading to increased FGF23 concentration and disordered bone development (Clinkenbeard. JBMR 2013). Children with rickets in rural Gambia, West Africa, have high prevalences of i...

ba0005cabs.oc4.2 | Oral Communications | ECTS2016

Bisphosphonates prevent osteolysis and muscle weakness in aromatase inhibitor-treated mice with breast cancer bone metastases

Wright Laura , Harhash Ahmed , Waning David , Mohammad Khalid , Marks Andrew , Guise Theresa

Up to half of women treated with an aromatase inhibitor (AI) for breast cancer develop muscle weakness, bone loss, and joint pain. Moreover, an elevated state of osteoclastic bone resorption has been shown to prime the bone microenvironment in ways that accelerate metastatic growth. We hypothesized that AI-induced bone loss could increase breast cancer progression in bone and exacerbate muscle weakness associated with bone metastases. Four-week female athymic nude mice underwe...

ba0005p3 | Arthritis and other joint diseases: translational and clinical | ECTS2016

The influence of secondary hyperparathyroidism -at the time of index operation- on the later development of (septic or aseptic) loosening of implants in female patients with knee osteoarthritis who undergo total knee arthroplasty

Papavasiliou Kyriakos , Michael Theodore , Tsitouras Dimosthenis , Karanassos Marinos , Adam Stergios , Kirkos John

Objectives: Prospective case-controlled study assessing whether the incidence of loosening of implants in patients undergoing Total Knee Arthroplasty (TKA) is higher among those with Secondary Hyperparathyroidism (SP) at the time of index operation.Material and methods: Caucasian female patients with knee osteoarthritis who underwent TKA between November 2004 and March 2007 were enrolled. Exclusion criteria: endocrinopathies, rheumatoid or secondary arth...